Global Markets for Generic Drugs

1
Global Markets for Generic Drugs
2
Summary

• The global market for generic drugs should reach
  533 billion by 2021 from 352 billion in 2016 at
  a compound annual growth rate (CAGR) of 8.7,
  from 2016 to 2021.
• INTRODUCTION
• STUDY GOALS AND OBJECTIVES
• The aim of this report is to provide detailed
  market, technology industry analyses to help
  readers quantify and qualify the market for
  prescription generic drugs. Importanttrends are
  identified sales forecasts by product
  categories and major country markets are provided
  through 2018 these are based on industry sources
  and consideredassessment of the regulatory
  environment, healthcare policies, demographics
  and other factors that directly affect the
  generic drug market. The wider economic
  environment is also taken into account.
• The report examines strategies employed by
  companies specializing in generics to meet the
  challenges of this highly competitive market,
  while also summarizing strategiesemployed by
  originator companies to respond to generic
  competition.

www.BharatBook.com
3
(No Transcript)
4
REASONS FOR DOING THE STUDY

• This is a time of growth change for the generic
  pharmaceutical sector. Major aspects that have
  combined to create an opportunity for an up-to
  date market analysis includethe following
• -The demand for generic is increasing steadily
  because of pressure to control healthcare costs.
  At the same time, fierce price competition in
  this area has put some companies in difficulties
  because of slashed profit margins. The main
  result has been a wave of MA activity, and the
  rise of supergenerics offering added value as
  well as low prices. Not all traditional companies
  are positioned to exploit this trend.
• -A major growth driver for the generics sector is
  the fact that several blockbusterpharmaceutical
  brands are coming off-patent and are therefore
  open to genericcompetition the phenomenon
  widely known as the patent cliff. But the
  originatorcompanies are deploying formidable
  strategies to protect their franchise,
  includingmarketing their own branded generics.
• -With first-generation biopharmaceutical products
  reaching the end of their patent lives, a whole
  new market field biogenerics, or biosimilars
  is opening up, for thosegenerics companies
  capable of (or prepared to buy in) the
  technological expertiserequired.
• -The international landscape is changing for
  generics as for all pharmaceuticals. TheBRIC
  nations (Brazil, Russia, India and China) are
  among rising centers of genericactivity.

www.BharatBook.com
5
SCOPE OF REPORT

• This report discusses the implications of all the
  above-mentioned trends, in the context of the
  current size and growth of the generics market,
  both in global terms and analyzed by the most
  important national markets. The nature
  structure of the generics industry is discussed,
  with profiles of the leading 20 generics
  companies an update on MA activity. Five-year
  sales forecasts are provided for the national
  markets and the majortherapeutic categories of
  products involved.

www.BharatBook.com
6
MARKET ANALYSES FORECASTS

• Market figures are based on revenues at the
  manufacturer level and are projected on the basis
  of 2016 dollar value without attempting to
  predict the effect of inflation/deflation.
• Therapeutic categories quantified and forecast
  include antibacterials, antidepressants,anticance
  r agents, anti-arthritics, cardiovascular drugs
  (e.g. hypolipidemics andantihypertensive) and
  drugs for respiratory conditions, including
  asthma and COPD.

www.BharatBook.com
7
METHODOLOGY

• Primary research includes interviews with leading
  individuals in generics companies,industry
  associations and regulatory bodies. Primary
  sources of published data include company annual
  reports, SEC filings, and government and industry
  publications.Secondary sources consist of
  literature searches, industry journals other
  commercial publications. Data for market
  estimates forecasts are pooled from a range of
  sources, critically assessed by Research team.

www.BharatBook.com
8
INTENDED AUDIENCE

• This report is designed to satisfy the
  information needs of a wide variety of
  individuals involved in the generics marketplace,
  including corporate senior management executive
  seeking to base their strategic decisions on the
  best available information on marketforces and
  trends. It is also aimed at managers and
  executives in marketing, research,planning and
  sales departments who need readable,
  comprehensive and up-to-date background on the
  marketplace in which they are operating.

www.BharatBook.com
9
INFORMATION SOURCES

• Sources of information included marketing
  strategists, industry executives, government
  agencies and regulatory bodies, and surveys of
  physicians and pharmacists. Companyannual
  reports and SEC filings, journal articles data
  from healthcare institutions were also mined, as
  well as publications of trade associations such
  as the GenericPharmaceutical Association (GPhA)
  and the European Generic Medicines Association
  (EGA).

www.BharatBook.com
10
Table of Contents

• Introduction
• Summary
• Overview
• The New Generics Era
• Major Generic Issues
• The Generics Market
• Generics Markets And Forecasts By Country
• The Global Generics Industry

www.BharatBook.com
11
Full Reports
Global Markets for Generic Drugs
Bharat Book Bureau Tel [phone] /
27810773 Email poonam_at_bharatbook.com Website
www.bharatbook.com FaceBook BharatBook3B Twitter
ResearchBook LinkedIn Bharat Book Bureau
12
Thank You